Evidence map›Paper›PMID 37071402›Full record

ArticleVector borne and zoonotic diseases (Larchmont, N.Y.)2023

The Landscape of Lyme Borreliosis Surveillance in Europe.

Archana Nagarajan, Jozica Skufca, Andrew Vyse, Andreas Pilz, Elizabeth Begier, Margarita Riera-Montes, Bradford D Gessner, James H Stark

Abstract read
In one paragraph

Article in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020).Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2023
    Pooled it
  2. Molecular detection ofOne health (Amsterdam, Netherlands) · 2026
    Article
  3. Review
  4. Lyme borreliosis.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Lyme carditis in Europe.Frontiers in microbiology · 2026
    Review
  9. Article
  10. Review
  11. Differential Exposure toPathogens (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Aseptic Meningitis Linked toTropical medicine and infectious disease · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Archana NagarajanP95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
Jozica SkufcaP95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
Andrew VyseVaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom.
Andreas PilzPfizer Global Medical Affairs, Vaccines, Vienna, Austria.
Elizabeth BegierVaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA.
Margarita Riera-MontesP95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
Bradford D GessnerVaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
James H StarkVaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.ORCID 0000-0002-0728-876X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lyme DiseaseTick-Borne DiseasesAnimalsEuropeIncidenceRisk FactorsUnited KingdomdashboardsEuropeLyme borreliosissurveillancevaccine

Identifiers

PMID37071402
PMCPMC10122255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.